Giulia Spallone

Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas

Elisabetta Botti, Giulia Spallone, Francesca Moretti et al. · Proceedings of the National Academy of Sciences · 2011 · 173 citations

Pharmacogenetics of psoriasis:<i>HLA-Cw6</i>but not<i>LCE3B/3C</i>deletion nor<i>TNFAIP3</i>polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

Marina Talamonti, E. Botti, Marco Galluzzo et al. · British Journal of Dermatology · 2013 · 143 citations

A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias

Francesca Moretti, Barbara Marinari, Nadia Lo Iacono et al. · Journal of Clinical Investigation · 2010 · 135 citations · Full text

Developmental Biology, Human Congenital Syndromes, Cell Regulation +12

A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy

Rosita Saraceno, Luigi Citarella, Giulia Spallone et al. · Clinical and Experimental Dermatology · 2007 · 42 citations

Biological Approach, Translational Medicine, Hypertension +15

Targeted Therapy in Nonmelanoma Skin Cancers

Giulia Spallone, Elisabetta Botti, Antonio Costanzo · Cancers · 2011 · 25 citations · Full text

Surgical Oncology, Nonmelanoma Skin Cancer, Several Targeted Therapies +12